Abivax S.A. - ABVX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 11, 2026 | SCHEDULE 13D/A | — | 4.3% | 82,047,884 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Invus Public Equities, L.P. | 5.0% | 3,922,995 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Invus Public Equities Advisors, LLC | 5.0% | 3,922,995 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Invus Global Management, LLC | 5.0% | 3,922,995 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Siren, L.L.C. | 5.0% | 3,922,995 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Raymond Debbane | 5.0% | 3,922,995 | View |
| Jan 14, 2026 | SCHEDULE 13D/A | — | 4.3% | 82,688,932 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.